Chiper Manuela, Niederreither Karen, Zuber Guy
Molecular and Pharmaceutical Engineering of Biologics, CNRS-Université de Strasbourg UMR 7242, Boulevard Sebastien Brant, F-67412, Illkirch, France.
Faculté de Pharmacie-Université de Strasbourg, 74 Route du Rhin, F-67400, Illkirch, France.
Adv Healthc Mater. 2018 Mar;7(6):e1701040. doi: 10.1002/adhm.201701040. Epub 2017 Dec 5.
The human organism and its constituting cells rely on interplay between multiple proteins exerting specific functions. Progress in molecular biotechnologies has facilitated the production of recombinant proteins. When administrated to patients, recombinant proteins can provide important healthcare benefits. To date, most therapeutic proteins must act from the extracellular environment, with their targets being secreted modulators or extracellular receptors. This is because proteins cannot passively diffuse across the plasma membrane into the cytosol. To expand the scope of action of proteins for cytosolic targets (representing more than 40% of the genome) effective methods assisting protein cytosolic entry are being developed. To date, direct protein delivery is extremely tedious and inefficient in cultured cells, even more so in animal models of pathology. Novel techniques are changing this limitation, as recently developed in vitro methods can robustly convey large amount of proteins into cell cultures. Moreover, advances in protein formulation or protein conjugates are slowly, but surely demonstrating efficiency for targeted cytosolic entry of functional protein in vivo in tumor xenograft models. In this review, various methods and recently developed techniques for protein transport into cells are summarized. They are put into perspective to address the challenges encountered during delivery.
人体及其组成细胞依赖于多种发挥特定功能的蛋白质之间的相互作用。分子生物技术的进步促进了重组蛋白的生产。当给予患者时,重组蛋白可以提供重要的医疗益处。迄今为止,大多数治疗性蛋白质必须在细胞外环境中发挥作用,其靶点是分泌型调节剂或细胞外受体。这是因为蛋白质不能被动地穿过质膜进入细胞质。为了扩大针对细胞质靶点(占基因组的40%以上)的蛋白质的作用范围,正在开发协助蛋白质进入细胞质的有效方法。迄今为止,直接蛋白质递送在培养细胞中极其繁琐且效率低下,在病理动物模型中更是如此。新技术正在改变这一限制,因为最近开发的体外方法可以将大量蛋白质强力输送到细胞培养物中。此外,蛋白质制剂或蛋白质缀合物的进展正在缓慢但肯定地证明在肿瘤异种移植模型中功能性蛋白质在体内靶向进入细胞质的效率。在这篇综述中,总结了蛋白质转运到细胞中的各种方法和最近开发的技术。对它们进行了展望,以应对递送过程中遇到的挑战。